Lee F. Allen M.D. Ph.D. is EVP & Chief Medical Officer at AMAG PHARMACEUTICALS INC. (AMAG). They have made 8 open-market trades across 2 companies since 2009, most recently 2019-11-12.
CIK 0001408474
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $118K since 2009, against 1 sale. Across 7 scored buys the stock is down 2.1% at ninety days, and 3.1 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 14% |
| Avg Move | -21.3% | -6.7% | -2.1% |
| Alpha | -16.6% | -7.3% | -3.1% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DOVA | SELL · 10b5-1 | 2019-09-30 | 2019-10-02 | $28.00 | $27K | +0.2% | +0.7% | N/A |
| DOVA | SELL · 10b5-1 | 2019-07-01 | 2019-07-02 | $14.19 | $28K | -2.7% | -4.4% | +69.4% |
| DOVA | BUY | 2017-07-05 | 2017-07-07 | $17.00 | $60K | -7.6% | -25.6% | +6.7% |
| AMAG | BUY | 2011-11-30 | 2011-12-02 | $15.13 | $4K | -23.6% | -3.6% | -3.6% |
| AMAG | SELL | 2011-08-11 | 2011-08-12 | $15.04 | $29K | -23.6% | -3.6% | -3.6% |
| AMAG | BUY | 2011-05-31 | 2011-06-01 | $13.23 | $17K | -23.6% | -3.6% | -3.6% |
| AMAG | BUY | 2010-12-01 | 2010-12-03 | $13.34 | $520 | -23.6% | -3.6% | -3.6% |
| AMAG | BUY | 2010-05-28 | 2010-06-01 | $27.06 | $17K | -23.6% | -3.6% | -3.6% |
| AMAG | BUY | 2009-12-01 | 2009-12-02 | $31.78 | $4K | -23.6% | -3.6% | -3.6% |
| AMAG | BUY | 2009-06-02 | 2009-11-13 | $25.61 | $16K | -23.6% | -3.6% | -3.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.